Guggenheim analyst Subbu Nambi reaffirmed a “Buy” rating on Tempus AI, Inc. (NASDAQ:TEM), while raising the firm’s price ...

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, is actively leveraging artificial intelligence (AI) ...

It is worth noting that Nvidia has been running away with the data center GPU market, with an estimated market share of 92% ...

When it comes to companies shaping the future of AI, one of the first to come to mind is Google's parent company, Alphabet ( ...

AI-related stocks topped trading activity on Robinhood U.K. in June, led by Nvidia (NASDAQ: NVDA), CoreWeave and Applied ...

Tempus AI (NasdaqGS:TEM) recently saw its market presence elevated as it was added to multiple Russell indices, showcasing an enhanced visibility. The company also bolstered its strategic partnerships ...

Healthcare is the most underappreciated AI beneficiary,” said Ark Invest CEO Cathie Wood in a recent statement that’s ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the 10 Stocks Crash Hard on a Roaring Monday. Tempus AI dropped for a second day on ...

Chicago-based Tempus AI, Inc. TEM is experiencing robust revenue growth, marked by record-setting financial performance. In ...

Tempus AI (NASDAQ:TEM – Get Free Report) had its price target upped by stock analysts at Guggenheim from $65.00 to $75.00 in ...

Broader macroeconomic uncertainty has resulted in continued caution for both investors and acquirers in the in vitro diagnostics sector.

Tempus AI, Inc. is currently listed on the NASDAQ under TEM. You can buy Tempus AI, Inc. stock in the US through any online brokerage account such as E*TRADE, Charles Schwab, or Merrill Edge.